Published articles

Published articles 4 records found  Search took 0.00 seconds. 
1.
19 p, 2.1 MB Effects of Rifaximin on Luminal and Wall-Adhered Gut Commensal Microbiota in Mice / Ferrer Clotas, Marina (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Aguilera Pujabet, Mònica (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Martínez Perea, Vicente (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Universitat Autònoma de Barcelona. Institut de Neurociències
Rifaximin is a broad-spectrum antibiotic that ameliorates symptomatology in inflammatory/functional gastrointestinal disorders. We assessed changes in gut commensal microbiota (GCM) and Toll-like receptors (TLRs) associated to rifaximin treatment in mice. [...]
2021 - 10.3390/ijms22020500
International journal of molecular sciences, Vol. 22, Núm. 2 (January 2021) , art. 500  
2.
16 p, 2.8 MB Anti-Trypanosoma cruzi Activity of Metabolism Modifier Compounds / Martinez-Peinado, Nieves (Institut de Salut Global de Barcelona) ; Cortés Serra, Núria (Institut de Salut Global de Barcelona) ; Sherman, Julian (New York University School of Medicine. Department of Microbiology) ; Rodriguez, Ana (New York University School of Medicine. Department of Microbiology) ; Gascon, Joaquim (Barcelona Institute for Global Health (ISGlobal)) ; Alberola, Jordi (Alberola i Domingo) (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Pinazo, Maria-Jesus (Institut de Salut Global de Barcelona) ; Rodríguez-Cortés, Alhelí (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Alonso-Padilla, Julio (Institut de Salut Global de Barcelona) ; Martori Muntsant, Clara (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia)
Chagas disease is caused by the protozoan parasite Trypanosoma cruzi and affects over 6 million people worldwide. Development of new drugs to treat this disease remains a priority since those currently available have variable efficacy and frequent adverse effects, especially during the long regimens required for treating the chronic stage of the disease. [...]
2021 - 10.3390/ijms22020688
International journal of molecular sciences, Vol. 22 Núm. 2 (2021) , p. 688  
3.
15 p, 2.7 MB Expression Levels of an Alpha-Synuclein Transcript in Blood May Distinguish between Early Dementia with Lewy Bodies and Parkinson's Disease / Marsal-García, Laura (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Campdelacreu, Jaume (Hospital Universitari de Bellvitge) ; Vilas, Dolores (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Ispierto, Lourdes (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Gascon-Bayarri, Jordi (Hospital Universitari de Bellvitge) ; Reñé, Ramón (Hospital Universitari de Bellvitge) ; Álvarez, Ramiro (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Beyer, Katrin (Institut Germans Trias i Pujol) ; Urbizu, Aintzane (Institut Germans Trias i Pujol) ; Arnaldo, Laura (Institut Germans Trias i Pujol) ; Universitat Autònoma de Barcelona
Lewy body diseases (LBD) including dementia with Lewy bodies (DLB) and Parkinson disease (PD) are characterized by alpha-synuclein pathology. DLB is difficult to diagnose and peripheral biomarkers are urgently needed. [...]
2021 - 10.3390/ijms22020725
International journal of molecular sciences, Vol. 22 Núm. 2 (2021) , p. 725  
4.
21 p, 5.3 MB Pathological ATX3 Expression Induces Cell Perturbations in E. coli as Revealed by Biochemical and Biophysical Investigations / Ami, Diletta (University of Milano-Bicocca. Department of Biotechnologies and Biosciences) ; Mereghetti, Paolo (Bioinformatics Consultant) ; Falvo, Jacopo (University of Milano-Bicocca. Department of Biotechnologies and Biosciences) ; Catelani, Tiziano (University of Milano-Bicocca. Department of Biotechnologies and Biosciences) ; Visentin, Cristina (Università degli Studi di Milano. Department of Biosciences) ; Tortora, Paolo (University of Milano-Bicocca. Department of Biotechnologies and Biosciences) ; Ventura, Salvador (Universitat Autònoma de Barcelona. Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Natalello, Antonino (University of Milano-Bicocca. Departament of Biotechnology and Biosciences) ; Regonesi, Maria Elena (Università di Milano-Bicocca. Dipartimento di Biotecnologie e Bioscienze) ; Sciandrone, Barbara (University of Milano-Bicocca. Department of Biotechnologies and Biosciences)
Amyloid aggregation of human ataxin-3 (ATX3) is responsible for spinocerebellar ataxia type 3, which belongs to the class of polyglutamine neurodegenerative disorders. It is widely accepted that the formation of toxic oligomeric species is primarily involved in the onset of the disease. [...]
2021 - 10.3390/ijms22020943
International journal of molecular sciences, Vol. 22, Issue 2 (January 2021) , art. 943  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.